Pyc Therapeutics Share Price and Company Fundamentals
Last traded: Today at 5:10 AM
PYC Therapeutics Limited, a drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia. The company offers VP-001, a drug program, which is in Phase 1 clinical trial for the treatment of retinitis pigmentosa type 11; PYC-001, a drug candidate for treating blinding eye disease named Autosomal Dominant Optic Atrophy, which is in clinical studies; PYC-002, a drug program for the treatment of severe neurodevelopmental disorder named Phelan-McDermid Syndrome, which is in pre-clinical studies; and PYC-003 to treat autosomal dominant polycystic kidney disease, which is in early-stage clinical trials. PYC Therapeutics Limited has academic-industry collaborations with Murdoch University to support drug discovery and development efforts in the field of neurodegenerative disorders. The company was formerly known as Phylogica Limited and changed its name to PYC Therapeutics Limited in November 2019. PYC Therapeutics Limited was incorporated in 2001 and is based in Nedlands, Australia.
Key Metrics
PE ratio
-
PB ratio
5.19
Dividend yield
-
Beta
0.89
Market cap
$901.86M
Enterprise value
$729.13M
Company profile
| Industry / Sector | Biotechnology / Healthcare |
|---|---|
| Website | https://pyctx.com |
| Mailing address | Harry Perkins Institute of Medical Research 6 Verdun Street Nedlands WA 6009 Australia |
| Phone / Fax | 61 8 6151 0992 / |
Dividends
More: Pyc Therapeutics Dividend history, yield and payout ratio
Dividend yield
-
Dividend amount
$-
Payout ratio
0.00%
5Y Avg. yield
-%
Pyc Therapeutics paid $- dividend and the ex-dividend date was -.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.PYC dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Pyc Therapeutics.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Dr. Rohan Hockings G.D.L.P, J.D., MBBS, MBBS (Hons.) | CEO & Executive Director | 42 | |
| Mr. Garrett Bray | Chief Operating Officer | ||
| Mr. Sean Houthuysen | General Counsel | ||
| Dr. Sri Mudumba | Chief Research & Development Officer | ||
| Dr. Paula Cunningham | Chief Pre-Clinical Research Officer | ||
| Dr. Janya Grainok | Chief Discovery Officer | ||
| Mr. Aaron Kidd | Chief Commercial Officer | ||
| Mr. Kevin Ronald Hart B.Com., B.Comm (Hons), C.A., F.C.A. | Company Secretary | 63 |
Profitability and management effectiveness
Profit margin
-214.11%
Operating margin
-231.06%
Return on assets
-24.42%
Return on equity
-40.64%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Pyc Therapeutics is 901.86M and its enterprise value is 729.13M. The enterprise value to revenue ratio of PYC is 31.03. The enterprise value to EBITDA ratio of PYC is -13.79.
The PYC's stocks Beta value is 0.89 making it 11% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Pyc Therapeutics (PYC)
Pyc Therapeutics (ASX:PYC) Frequently Asked Questions
1. What is Pyc Therapeutics's Stock Symbol?
Pyc Therapeutics trades on ASX under the ticker symbol "PYC".
2. What is Pyc Therapeutics's stock price today?
One share of PYC stock can currently be purchased for approximately $1.51.
3. How can I contact Pyc Therapeutics?
Pyc Therapeutics's mailing address is Harry Perkins Institute of Medical Research 6 Verdun Street Nedlands WA 6009 Australia. The company can be reached via phone at 61 8 6151 0992.
4. What is Pyc Therapeutics's official website?
The official website of Pyc Therapeutics is https://pyctx.com.